Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis

References

• Diotallevi F, Gioacchini H, De Simoni E, et al. Vitiligo, from pathogenesis to therapeutic advances: state of the art. Int J Mol Sci. 2023;24(5):1. doi: 10.3390/ijms24054910.
   Web of Science ®Google Scholar
• Alomrani AH, Alhazza FI, AlGhamdi KM, et al. Effect of neat and binary vehicle systems on the solubility and cutaneous delivery of piperine. Saudi Pharm J. 2018;26(2):162–12. doi: 10.1016/j.jsps.2017.12.015.
   PubMed Web of Science ®Google Scholar
• Hu SH, Jiang S, Miao F, et al. sPmel17 secreted by ultraviolet B-Exposed melanocytes alters the intercellular adhesion of keratinocytes. Oxid Med Cell Longev. 2022;2022:1856830–1856812. doi: 10.1155/2022/1856830.
   PubMed Web of Science ®Google Scholar
• Gandhi K, Ezzedine K, Anastassopoulos KP, et al. Prevalence of vitiligo among adults in the United States. JAMA Dermatol. 2022;158(1):43–50. doi: 10.1001/jamadermatol.2021.4724.
   PubMed Web of Science ®Google Scholar
• Bibeau K, Pandya AG, Ezzedine K, et al. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA. J Eur Acad Dermatol Venereol. 2022;36(10):1831–1844. doi: 10.1111/jdv.18257.
   PubMed Web of Science ®Google Scholar
• Yang R, Zheng Y, Li L, et al. Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat Commun. 2014;5(1):5807. doi: 10.1038/ncomms6807.
   PubMedGoogle Scholar
• Picardo M, Huggins RH, Jones H, et al. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36(9):1507–1523. doi: 10.1111/jdv.18129.
   PubMed Web of Science ®Google Scholar
• Smith MP, Ly K, Thibodeaux Q, et al. Home phototherapy for patients with vitiligo: challenges and solutions. Clin Cosmet Investig Dermatol. 2019;12:451–459. doi: 10.2147/ccid.S185798.
   PubMed Web of Science ®Google Scholar
• Lopes C, Trevisani VF, Melnik T. Efficacy and safety of 308-nm monochromatic excimer lamp versus other phototherapy devices for vitiligo: a systematic review with meta-analysis. Am J Clin Dermatol. 2016;17(1):23–32. doi: 10.1007/s40257-015-0164-2.
   PubMed Web of Science ®Google Scholar
• Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38(1):621–648. doi: 10.1146/annurev-immunol-100919-023531.
   PubMedGoogle Scholar
• Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol. 2012;51(9):1107–1115. doi: 10.1111/j.1365-4632.2011.05454.x.
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Ezzedine K, Hamzavi I, et al. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017;77(1):17–29. doi: 10.1016/j.jaad.2016.11.010.
   PubMed Web of Science ®Google Scholar
• Mohammad TF, Al-Jamal M, Hamzavi IH, et al. The vitiligo working group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo. J Am Acad Dermatol. 2017;76(5):879–888. doi: 10.1016/j.jaad.2016.12.041.
   PubMed Web of Science ®Google Scholar
• Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(7):666–674. doi: 10.1001/jamadermatol.2017.0002.
   PubMed Web of Science ®Google Scholar
• Zhu B, Liu C, Zhang L, et al. Comparison of NB-UVB combination therapy regimens for vitiligo: a systematic review and network meta-analysis. J Cosmet Dermatol. 2023;22(3):1083–1098. doi: 10.1111/jocd.15534.
   PubMed Web of Science ®Google Scholar
• Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. Br J Dermatol. 2012;167(3):468–478. doi: 10.1111/j.1365-2133.2012.11008.x.
   PubMed Web of Science ®Google Scholar
• Bae JM, Hong BY, Lee JH, et al. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials (RCTs). J Am Acad Dermatol. 2016;74(5):907–915. doi: 10.1016/j.jaad.2015.11.044.
   PubMed Web of Science ®Google Scholar
• Bapur Erduran F, Adışen E. Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo. Photodermatol Photoimmunol Photomed. 2016;32(5–6):247–253. doi: 10.1111/phpp.12266.
   PubMed Web of Science ®Google Scholar
• Nisticò S, Chiricozzi A, Saraceno R, et al. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. Photomed Laser Surg. 2012;30(1):26–30. doi: 10.1089/pho.2011.3029.
   PubMed Web of Science ®Google Scholar
• Soliman M, Samy NA, Abo Eittah M, et al. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo. J Cosmet Laser Ther. 2016;18(1):7–11. doi: 10.3109/14764172.2015.1052510.
   PubMed Web of Science ®Google Scholar
• Juntongjin P, Toncharoenphong N. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study. Lasers Med Sci. 2020;35(9):2023–2029. doi: 10.1007/s10103-020-03048-5.
   PubMed Web of Science ®Google Scholar
• Fenniche S, Zaouak A, Tanfous AB, et al. Successful treatment of refractory vitiligo with a combination of khellin and 308-nm excimer lamp: an open-label, 1-year prospective study. Dermatol Ther (Heidelb). 2018;8(1):127–135. doi: 10.1007/s13555-017-0218-x.
   PubMed Web of Science ®Google Scholar
• Deng Y, Li J, Yang G. 308-nm excimer laser plus platelet-rich plasma for treatment of stable vitiligo: a prospective, randomized case-control study. Clin Cosmet Investig Dermatol. 2020;13:461–467. doi: 10.2147/ccid.S260434.
   PubMed Web of Science ®Google Scholar
• Yazdani Abyaneh M, Griffith RD, Falto-Aizpurua L, et al. Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies. J Eur Acad Dermatol Venereol. 2014;28(12):1610–1622. doi: 10.1111/jdv.12619.
   PubMed Web of Science ®Google Scholar
• Farag HM, Yunusa I, Goswami H, et al. Comparison of amitriptyline and US food and drug administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis. JAMA Netw Open. 2022;5(5):e2212939. doi: 10.1001/jamanetworkopen.2022.12939.
   PubMed Web of Science ®Google Scholar
• Iheozor-Ejiofor Z, Gordon M, Clegg A, et al. Interventions for maintenance of surgically induced remission in crohn’s disease: a network meta-analysis. Cochrane Database Syst Rev. 2019;9(9):Cd013210. doi: 10.1002/14651858.CD013210.pub2.
   PubMedGoogle Scholar
• Loy JH, Merry SN, Hetrick SE, et al. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev. 2017;8(8):Cd008559. doi: 10.1002/14651858.CD008559.pub3.
   PubMedGoogle Scholar
• Kanie T, Mizuno A, Takaoka Y, et al. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;10(10):Cd013650. doi: 10.1002/14651858.CD013650.pub2.
   PubMedGoogle Scholar
• Elsaadany AE, El-Khalawany M, Elshahid AR, et al. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo. J Cosmet Dermatol. 2022;21(7):2826–2831. doi: 10.1111/jocd.14582.
   PubMed Web of Science ®Google Scholar
• Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study. J Cosmet Dermatol. 2020;19(4):869–877. doi: 10.1111/jocd.13103.
   PubMed Web of Science ®Google Scholar
• Juntongjin P, Sangganjanavanich P. Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double-blind comparative study. Dermatol Ther. 2021;34(2):e14886. doi: 10.1111/dth.14886.
   PubMed Web of Science ®Google Scholar
• Lu-Yan T, Wen-Wen F, Lei-Hong X, et al. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2006;22(6):310–314. doi: 10.1111/j.1600-0781.2006.00250.x.
   PubMed Web of Science ®Google Scholar
• Ghalamkarpour F, Robati R, Ghasir G, et al. The 308-nm xenon chloride excimer laser in combination with topical calcipotriol in the treatment of vitiligo. Iran J Dermatol. 2011;14(1):12–15.
   Google Scholar
• Sassi F, Cazzaniga S, Tessari G, et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol. 2008;159(5):1186–1191. doi: 10.1111/j.1365-2133.2008.08793.x.
   PubMed Web of Science ®Google Scholar
• Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140(9):1065–1069. doi: 10.1001/archderm.140.9.1065.
   PubMedGoogle Scholar
• Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30(2 Pt 1):130–135. doi: 10.1111/j.1524-4725.2004.30058.x.
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev. 2021;41(2):1138–1166. doi: 10.1002/med.21754.
   PubMed Web of Science ®Google Scholar
• Sun C, Shan F, Liu M, et al. High-fat-diet-induced oxidative stress in giant freshwater prawn (macrobrachium rosenbergii) via NF-κB/NO signal pathway and the amelioration of vitamin E. Antioxidants (Basel). 2022;11(2):228. doi: 10.3390/antiox11020228.
   Google Scholar
• Ma J, Li S, Zhu L, et al. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway. Free Radic Biol Med. 2018;129:492–503. doi: 10.1016/j.freeradbiomed.2018.10.421.
   PubMed Web of Science ®Google Scholar
• Arowojolu OA, Orlow SJ, Elbuluk N, et al. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol. 2017;26(7):637–644. doi: 10.1111/exd.13350.
   PubMed Web of Science ®Google Scholar
• Jian Z, Li K, Song P, et al. Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J Invest Dermatol. 2014;134(8):2221–2230. doi: 10.1038/jid.2014.152.
   PubMed Web of Science ®Google Scholar
• Zedan H, Abdel-Motaleb AA, Kassem NM, et al. Low glutathione peroxidase activity levels in patients with vitiligo. J Cutan Med Surg. 2015;19(2):144–148. doi: 10.2310/7750.2014.14076.
   PubMed Web of Science ®Google Scholar
• Kang P, Chen J, Zhang W, et al. Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo. Cell Death Discov. 2022;8(1):70. doi: 10.1038/s41420-022-00863-3.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kawamoto S, Ohtani N, et al. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases. Cancer Sci. 2017;108(4):563–569. doi: 10.1111/cas.13184.
   PubMed Web of Science ®Google Scholar
• Lei T-C, Xu A-E, Gao T-W, et al. Consensus on the diagnosis and treatment of vitiligo in China (2021 revision). Int J Dermatol Venereol. 2021;4(1):10–15. doi: 10.1097/JD9.0000000000000151.
   Google Scholar
• Dellatorre G, Antelo DAP, Bedrikow RB, et al. Consensus on the treatment of vitiligo - Brazilian society of dermatology. An Bras Dermatol. 2020;95(Suppl 1):70–82. doi: 10.1016/j.abd.2020.05.007.
   PubMedGoogle Scholar
• Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of vitiligo: the european dermatology forum consensus. Br J Dermatol. 2013;168(1):5–19. doi: 10.1111/j.1365-2133.2012.11197.x.
   PubMed Web of Science ®Google Scholar
• Leone G, Paro Vidolin A. Effect of an antioxydant cream versus placebo in patients with vitiligo in association with excimer laser. A pilot randomized, investigator-blinded, and half-side comparison trial. G Ital Dermatol Venereol. 2015;150(4):461–466.
   PubMed Web of Science ®Google Scholar
• Chang WL, Ko CH. The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications. Cells. 2023;12(6):936. doi: 10.3390/cells12060936.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yi X, Su X, et al. Ginkgo biloba extract protects human melanocytes from H(2) O(2)-induced oxidative stress by activating Nrf2. J Cell Mol Med. 2019;23(8):5193–5199. doi: 10.1111/jcmm.14393.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Khan M, Jiang L, et al. The current status of antioxidants in the treatment of vitiligo in China. Oxid Med Cell Longev. 2022;2022:2994558–2994513. doi: 10.1155/2022/2994558.
   PubMed Web of Science ®Google Scholar
• Silpa-Archa N, Lim HW, Wongpraparut C. Excimer laser in vitiligo: where there is light, there is hope. Br J Dermatol. 2019;181(1):21–22. doi: 10.1111/bjd.18101.
   PubMed Web of Science ®Google Scholar
• Bae JM, Kwon SH, Ju HJ, et al. Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: a randomized controlled trial. J Am Acad Dermatol. 2020;83(5):1463–1464. doi: 10.1016/j.jaad.2020.03.009.
   PubMed Web of Science ®Google Scholar
• Post NF, Ezekwe N, Narayan VS, et al. The use of lasers in vitiligo, an overview. J Eur Acad Dermatol Venereol. 2022;36(6):779–789. doi: 10.1111/jdv.18005.
   PubMed Web of Science ®Google Scholar